Join the Australasian Professional Society on Alcohol and other Drugs (APSAD) their 2024 Conference in Canberra.

The Conference theme reflects the move towards greater Inclusion of multiple and varied voices in alcohol, tobacco and other drug issues, including greater participation by people with lived and/or living experience of alcohol and other drugs in the processes of program development and delivery; research and evaluation; and policy reform. Similarly, it reflects the broad range of professional and practical expertise in our sector across a variety of settings.

Speakers

Paul Liknaitzky, Head of the Clinical Psychedelic Lab, and Senior Research Fellow within the Deptartment of Psychiatry at Monash University.

Paul’s work is focused on investigating novel applications for psychedelic therapies, translating evidence into best clinical practice, exploring under-examined risks, delivering next-generation therapist training, and improving access and affordability. He leads the country’s largest and most experienced group of psychedelic researchers and clinicians, is involved in numerous psychedelic studies across Australia, and collaborates with many international experts and organisations in the field.

Dr Heather Gifford (PhD), Whakauae Research for Māori Health and Development.

Heather is a Maori health researcher with strong ties to her iwi, Ngāti Hauiti and Ātihaunui a Pāpārangi. She established Whakauae Research for Māori Health and Development, a tribally owned Māori health research centre in Aotearoa. Heather’s research interests, for the last twenty years, have focused on tobacco control within a broader context of public policy, equity and health service delivery and intervention.

Jurgen Rehm, Senior Scientist, Institute for Mental Health Policy Research & Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, Canada

He is Professor and was the Inaugural Chair of Addiction Policy in the Dalla Lana School of Public Health at the University of Toronto, and he also holds other professorships and positions in Canada, Germany and Spain.

Dr. Rehm has been a leader in generating and analyzing the scientific data needed to inform clinicians and policy-makers of strategies to reduce alcohol-, tobacco-, and other drug-attributable harm.  His recent research has increasingly included interactions between socio-economic status, poverty and substance use, including analysis of policies and interventions with respect to reducing or increasing inequalities.

His work has been awarded with numerous awards and prizes, most importantly, the Jellinek Memorial Award (2003), the European Addiction Research Award (2017) and the (Inaugural) Kettil Bruun Society Award for Advancement of International Research Collaboration (2021).

Tickets

APSAD Member Rates